The Valley Desk

ArticleCirculation. Genomic and precision medicinePublished

Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Circulation. Genomic and precision medicine
Published
Subject terms
Humans; Diabetes Mellitus, Type 2; Lipoprotein Lipase; Triglycerides; Polymorphism, Single Nucleotide; Middle Aged; Female; Male; Apolipoprotein C-III; Coronary Artery Disease; Mendelian Randomization Analysis; Hypolipidemic Agents
PubMed ID
40052268
PubMed Central ID
PMC7617573
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal